首页> 外国专利> CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION COMPRISING ACTIVE INGREDIENT, EXCIPIENTS, A METHYLVINYLETHER/MALEIC ANHYDRIDE POLYMER (DERIVATIVE) AND AT LEAST ONE OF PVP, PVA, PEG, ALGINIC ACID, CELLULOSE(S), STARCH(ES) AND VARIOUS GUMS

CONTROLLED-RELEASE PHARMACEUTICAL COMPOSITION COMPRISING ACTIVE INGREDIENT, EXCIPIENTS, A METHYLVINYLETHER/MALEIC ANHYDRIDE POLYMER (DERIVATIVE) AND AT LEAST ONE OF PVP, PVA, PEG, ALGINIC ACID, CELLULOSE(S), STARCH(ES) AND VARIOUS GUMS

机译:受控释放的药物成分,包含活性成分,赋形剂,甲基乙烯基醚/马来酸酐聚合物(衍生物),并且至少包含PVP,PVA,PEG,藻酸,纤维素,淀粉和各种胶

摘要

Bioadhesive pharmaceutical composition for the controlled release of active principles locally through the buccal cavity or systemically through a mucous membrane, characterised in that it is composed of an active principle, of a compound (A), of a compound (B) and of excipients as defined in the description.
机译:用于通过颊腔局部或通过粘膜局部控制释放活性成分的生物粘合剂药物组合物,其特征在于它由活性成分,化合物(A),化合物(B)和作为赋形剂的赋形剂组成。在说明中定义。

著录项

  • 公开/公告号NZ264500A

    专利类型

  • 公开/公告日1996-07-26

    原文格式PDF

  • 申请/专利权人 ADIR ET CIE;

    申请/专利号NZ19940264500

  • 发明设计人 RAULT ISABELLE;PICHON GERALD;CUINE ALAIN;

    申请日1994-09-21

  • 分类号A61K47/32;A61K47/36;A61K47/38;A61K47/40;A61K9/22;

  • 国家 NZ

  • 入库时间 2022-08-22 03:53:03

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号